Biohaven completes enrollment in focal epilepsy drug trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. EAT

Go back to Biohaven completes enrollment in focal epilepsy drug trial
(NYSE: BHVN) Delayed: 15.69 -0.17 (1.07%)
Previous Close $15.86    52 Week High $ 
Open $15.52    52 Week Low $ 
Day High $15.81    P/E N/A 
Day Low $15.21    EPS $ 
Volume 1,901,049